drugset / Trial / NCT04705337
Levosimendan In Ambulatory Heart Failure Patients
Phase 4
Terminated
70 enrolled
Medical University of Bialystok
Azienda Ospedaliera dei Colli · collabJohn Paul II Hospital, Krakow · collabMedical Research Agency, Poland · collabMedical University of Lodz · collabNational Institute of Cardiology, Warsaw, Poland · collabNicolaus Copernicus University · collabPoznan University of Medical Sciences · collabUniversity of Opole · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the study is to determine the efficacy of repeated infusions of levosimendan in the group of outpatients with advanced systolic heart failure (HF).
Timeline
- Start
- 2021-12-15
- Primary completion
- 2024-02-29
- Completion
- 2024-08-15
Outcome
Outcome not reported
Stopped (Enrollment): “The level of recruitment, 62 participants enrolled, does not allow for achieving the protocol-defined target of 350 participants by the end of the recruitment period.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | — | Intravenous |